News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Essilor Acquires Prescription Laboratories in the United Kingdom and the United States



12/6/2007 6:17:59 AM

CHARENTON-LE-PONT, France, December 6 /PRNewswire-FirstCall/ -- Essilor has strengthened its prescription laboratory network in Europe with the acquisition of majority stakes in Sinclair Optical Services and United Optical, two independent laboratories in the United Kingdom. The Company has also acquired Premier Optics, Inc., Gold Optical Enterprises, Inc. and GK Optical in the United States.

Based in Gloucester, England, Sinclair Optical serves the entire English market with a broad array of products that includes stock lenses, prescription lenses and surface treatments. Its full-year sales amount to EUR8 million. United Optical is located in Belfast, North Ireland. It also operates a subsidiary in Athlone, Ireland that specializes in the edging and mounting of prescription safety lenses. United Optical generates full-year revenue of around EUR5.8 million.

In the United States, Essilor of America has acquired the assets of Premier Optics, Inc. and Gold Optical Enterprises, Inc., two prescription laboratories located, respectively, in Belmont and Fayetteville, North Carolina. Essilor has also acquired GK Optical, a group of two prescription laboratories in Greenwood and Fort Wayne, Indiana. The three companies' combined full-year revenue totals $8.5 million.

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(R), Crizal(R), Essilor(R) and Definity(TM) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 244 lens finishing laboratories and local distribution networks. The Essilor share trades on the Euronext Paris market and is included in the CAC 40 index. Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF:FP.

http://www.essilor.com

CONTACT: Contacts: Investor Relations and Financial Communications,
Veronique Gillet, Phone: +33-1-49-77-42-16


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES